Bioactivity:

Relugolix is an orally available, non-peptide gonadotropin-releasing hormone (GnRH or luteinizing hormone-releasing hormone (LHRH)) antagonist, with potential antineoplastic activity. Relugolix competitively binds to and blocks the GnRH receptor in the an

CAS nr:

737789-87-6

Purity:

98%

Molecular Weight:

623,63

SMILES:

CN(C)Cc1c(sc2c1c(=O)n(c(=O)n2Cc1c(cccc1F)F)c1nnc(cc1)OC)c1ccc(cc1)NC(=O)NOC

Formula:

C29H27F2N7O5S

Pathway:

GPCR/G Protein

Target:

GNRH Receptor